Trupanion (NASDAQ:TRUP) Price Target Raised to $45.00

Trupanion (NASDAQ:TRUPFree Report) had its target price raised by Northland Securities from $35.00 to $45.00 in a research report released on Thursday, Benzinga reports. The brokerage currently has a market perform rating on the financial services provider’s stock.

Several other research firms have also weighed in on TRUP. Stifel Nicolaus reissued a hold rating and issued a $30.00 target price (up previously from $22.00) on shares of Trupanion in a report on Friday, August 9th. Evercore ISI upgraded Trupanion to a strong-buy rating in a research report on Friday, August 9th. Piper Sandler upped their price objective on Trupanion from $30.00 to $38.00 and gave the company a neutral rating in a research report on Friday, August 9th. Finally, William Blair initiated coverage on Trupanion in a research report on Friday, July 19th. They issued an outperform rating on the stock. Four research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Trupanion has an average rating of Moderate Buy and a consensus target price of $39.00.

Check Out Our Latest Analysis on Trupanion

Trupanion Trading Up 1.9 %

Shares of TRUP stock opened at $42.80 on Thursday. The business’s fifty day moving average price is $40.56 and its 200 day moving average price is $31.75. Trupanion has a 1-year low of $19.14 and a 1-year high of $49.14. The firm has a market capitalization of $1.80 billion, a PE ratio of -66.88 and a beta of 1.74. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.04. The company had revenue of $314.80 million for the quarter, compared to analyst estimates of $309.33 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. Trupanion’s revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.33) earnings per share. As a group, sell-side analysts forecast that Trupanion will post -0.37 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 8,764 shares of company stock worth $405,238. 5.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Trupanion

A number of large investors have recently modified their holdings of the stock. EP Wealth Advisors LLC acquired a new stake in shares of Trupanion in the second quarter valued at about $294,000. AQR Capital Management LLC grew its stake in shares of Trupanion by 173.8% in the second quarter. AQR Capital Management LLC now owns 43,553 shares of the financial services provider’s stock valued at $1,280,000 after buying an additional 27,644 shares in the last quarter. Marshall Wace LLP grew its stake in shares of Trupanion by 11.9% in the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after buying an additional 116,496 shares in the last quarter. Public Sector Pension Investment Board grew its stake in shares of Trupanion by 7.3% in the second quarter. Public Sector Pension Investment Board now owns 79,555 shares of the financial services provider’s stock valued at $2,339,000 after buying an additional 5,405 shares in the last quarter. Finally, Dalton Investments Inc. acquired a new stake in shares of Trupanion in the second quarter valued at about $1,029,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

See Also

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.